In 2006, Edward Gilhuly and Scott Stuart founded Sageview Capital, an investment firm that currently has about $800 million in assets under management. The strategy employed by Sageview involves focusing on long-term investments with a strong fundamental foundation. Insider Monkey follows the activity of Sageview Capital as part of our strategy, which allows “monkeys” to beat the market by as much as 18 percentage points per year. (See more details about our strategy here)
Sageview characterizes the best investment opportunities as represented by “high returns on capital, substantial free cash flow generation, attractive growth opportunities, sustainable barriers to entry, and strong management teams”. Generally, hedge funds
use a variety of strategies.
In this way, we should take a look at the largest picks in the equity portfolio of Sageview Capital. In first place is EverBank Financial Corp (NYSE:EVER),
represented by an almost $198.9 million stake, which involves about 12.9 million shares. The position remained
unchanged since the end of 2012.
In COMSCORE, Inc. (NASDAQ:SCOR),
the hedge fund reported ownership of about 2.9 million shares, worth about $49 million. Since the end of last year, the position of Sageview in COMSCORE, Inc. (NASDAQ:SCOR
) remained also unchanged. The stock of COMSCORE, Inc. (NASDAQ:SCOR
) has returned over 107% since the beginning of the year.
The next on the list is Resolute Energy Corp (NYSE:REN)
. The hedge fund disclosed a $24.4 million position, which contains about 2.1 million shares. Aside from Sageview, 10 hedge funds held shares of Resolute Energy Corp (NYSE:REN
) at the end of first quarter of 2013.
In fourth is Accretive Health, Inc. (NYSE:AH),
represented in the equity portfolio of Sageview by an almost 2 million share stake, which is valued at $20.3 million. Since the end of the last quarter of 2012, the hedge fund more than doubled its stake, from 869,500 shares, worth $10 million, advancing it one position up in its 13F portfolio. The year-to-date return of Accretive Health, Inc. (NYSE:AH
) is below -10%.
We should also mention Pernix Therapeutics Holdings Inc (NASDAQ:PTX)
, in which Sageview holds about 2.2 million shares, worth $17.3 million, an unchanged position since the previous round of 13F filings. In addition to Sageview, Renaissance Technologies managed by Jim Simons
, and Samuel Isaly
‘s Orbimed Advisors held shares in Pernix Therapeutics Holdings Inc (NASDAQ:PTX